MARKET

ICAD

ICAD

ICAD US
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.32
+0.33
+1.94%
After Hours: 16.50 -0.82 -4.73% 17:31 05/07 EDT
OPEN
16.89
PREV CLOSE
16.99
HIGH
17.65
LOW
16.89
VOLUME
62.78K
TURNOVER
--
52 WEEK HIGH
21.44
52 WEEK LOW
8.32
MARKET CAP
432.71M
P/E (TTM)
-53.6721
1D
5D
1M
3M
1Y
5Y
Brainsway Taps R. Scott Areglado as Finance Chief
MT Newswires · 3d ago
10-Q: ICAD INC
Edgar Online - (EDG = 10Q, 10K) · 4d ago
Medical Automation Market 2021 Development, Share, News and significant Growth with Regional Trends by Forecast 2028 | Says Kenneth Research
May 03, 2021 (AmericaNewsHour) -- Kenneth Research recently added a report on Medical Automation Market in its database of market research reports which...
AmericaNewsHour · 5d ago
What are The Major Factors Expected to Limit The Growth Of The Radiotherapy Devices Market?
Heraldkeepers · 04/30 09:44
DJ iCAD, Inc. CEO Michael Klein on Q1 2021 Results -- Earnings Call Transcript >ICAD
Dow Jones · 04/29 04:55
Analysts Offer Insights on Technology Companies: iCAD (ICAD) and BlackBerry (BB)
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on iCAD (ICAD) and BlackBerry (BB). iCAD (ICAD) Oppenheimer
SmarterAnalyst · 04/29 04:25
iCAD (ICAD) Receives a Buy from BTIG
BTIG analyst Marie Thibault reiterated a Buy rating on iCAD (ICAD) yesterday and set a price target of $25.00. The company's shares closed last Wednesday
SmarterAnalyst · 04/29 01:35
8-K: ICAD INC
(EDGAR Online via COMTEX) -- 0000749660 false ICAD INC 0000749660 2021-04-27 2021-04-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/28 22:21
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICAD. Analyze the recent business situations of ICAD US through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICAD stock price target is 24.40 with a high estimate of 30.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 125
Institutional Holdings: 11.96M
% Owned: 47.87%
Shares Outstanding: 24.98M
TypeInstitutionsShares
Increased
29
1.48M
New
10
510.83K
Decreased
36
1.05M
Sold Out
5
73.35K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.95%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Chairman/Chief Executive Officer/Executive Director/Director
Michael Klein
President
Stacey Stevens
Chief Financial Officer/Secretary
Charles Carter
Chief Technology Officer
Jonathan Go
Independent Director
Nathaniel Dalton
Independent Director
Rakesh Patel
Independent Director
Andrew Sassine
Independent Director
Susan Wood
No Data
About ICAD
iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

Webull offers kinds of iCAD Inc stock information, including NASDAQ:ICAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICAD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICAD stock methods without spending real money on the virtual paper trading platform.